Does Sensus Healthcare, Inc. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores Sensus Healthcare, Inc. (SRTS) 45.9 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 90, returns on capital 11, balance-sheet safety 55, capital discipline 24.

Is SRTS stock trading below its intrinsic value?

Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $3.11 per share versus a recent price of $3.02 — 3% below value. This is an educational estimate computed from primary SEC filings, not investment advice.

How has SRTS's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 45.9 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

Sensus Healthcare, Inc.

SRTS · Healthcare · $49.7M mkt cap · FY2025 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat

The four filters

Pricing power90

Median gross margin 63.4% over 10y, stable.

Returns on capital11

Median ROIC -5.3%, above the 9% hurdle in 30% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline24

Owner earnings trend unclear, share count growing (dilution).

Margin of safety

Above valueOn sale

3% below value

Owner earnings (normalized): $4.6M
Est. intrinsic value / share: $3.11
Recent price: $3.02
Discount to value: 3% below value

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for SRTS yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale45.9 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — SRTS has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#157 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#155CYH COMMUNITY HEALTH SYSTEMS, INC.46.0 out of 100, Shallow moatShallow moat
#156ITRI Itron, Inc.45.9 out of 100, Shallow moatShallow moat
#158BLFS BioLife Solutions, Inc.45.8 out of 100, Shallow moatShallow moat
#159IBRX IMMUNITYBIO, INC.45.8 out of 100, Shallow moatShallow moat

Compare SRTS with its nearest peers →All Healthcare companies on the Index →

Common questions about SRTS

Does Sensus Healthcare, Inc. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores Sensus Healthcare, Inc. (SRTS) 45.9 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 90, returns on capital 11, balance-sheet safety 55, capital discipline 24.
Is SRTS stock trading below its intrinsic value?: Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $3.11 per share versus a recent price of $3.02 — 3% below value. This is an educational estimate computed from primary SEC filings, not investment advice.
How has SRTS's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 45.9 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows SRTS’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/SRTS"
  width="340" height="150" style="border:0"
  title="SRTS Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell SRTS. See the disclaimer.